Latest Ceo Transition News

Page 3 of 8
Proteomics International Laboratories announces the planned retirement of its founder and Managing Director, Dr Richard Lipscombe, in February 2026, marking a pivotal leadership transition as the company seeks a new CEO to drive its next growth phase.
Ada Torres
Ada Torres
9 Sept 2025
Fluence Corporation Limited reported a robust 64.7% revenue increase to $33.1 million in H1 2025, driven by the Ivory Coast Addendum project and a strategic pivot to high-margin solutions. The company improved EBITDA to a positive $0.1 million and reduced fixed costs, signaling progress in its operational realignment.
Victor Sage
Victor Sage
29 Aug 2025
Acrux Ltd reported a 44% revenue decline and a modest increase in net loss for FY25, while expanding its US topical generics portfolio and entering the Saudi Arabian market. The company signals a strategic pivot amid intensifying competition and lower returns.
Victor Sage
Victor Sage
29 Aug 2025
Karoon Energy reported a 4% production increase in H1 2025 but saw underlying net profit after tax plunge 61%, driven by lower sales volumes and pricing. The company upgraded Baúna Project reserves by 35% and extended field life by seven years, while preparing for a CEO transition.
Maxwell Dee
Maxwell Dee
27 Aug 2025
PlaySide Studios reported a 25% revenue decline to $48.7 million for FY25, resulting in a $12.1 million net loss. The company is banking on new game launches and cost savings to reverse the downturn in FY26.
Sophie Babbage
Sophie Babbage
27 Aug 2025
Mach7 Technologies Limited reported a 16% revenue increase to AUD 33.8 million for FY25, alongside a 22% reduction in net loss, driven by a strategic shift to subscription-based sales and disciplined cost management.
Victor Sage
Victor Sage
27 Aug 2025
Lovisa Holdings delivered a robust FY25 with 14.2% sales growth, margin expansion, and over 160 new stores globally, setting a confident tone for FY26.
Logan Eniac
Logan Eniac
27 Aug 2025
Kip McGrath Education Centres reported solid FY25 growth in revenue and EBITDA from continuing operations, marked by a strategic exit from the USA and a new share buy-back program.
Victor Sage
Victor Sage
26 Aug 2025
Integral Diagnostics Limited (ASX – IDX) reported a robust FY25 performance, boosted by its transformative merger with Capitol Health Limited. The company posted strong revenue and profit growth, declared a 4.0 cent final dividend, and outlined strategic priorities including AI adoption and teleradiology expansion.
Ada Torres
Ada Torres
26 Aug 2025
Tyro Payments reported modest transaction growth and a 10.6% rise in EBITDA for FY25, while preparing for a CEO change and expanding into new industry verticals.
Claire Turing
Claire Turing
26 Aug 2025
Michael Hill International reported a steady FY25 with revenue holding firm at $643.7 million and a return to profitability despite ongoing retail challenges. The year saw strategic store closures, digital sales growth, and leadership changes, setting the stage for a reset under new CEO Jonathan Waecker.
Logan Eniac
Logan Eniac
25 Aug 2025
Endeavour Group reported a slight revenue decline and a 16% drop in profit for FY25, alongside significant leadership changes including the appointment of a new CEO. The company is advancing its technology separation and sustainability initiatives while maintaining dividend payments.
Victor Sage
Victor Sage
25 Aug 2025